Table 2 Histology, treatment, and follow up data of patients
Patients | Histological type + IHC | Tumor size | Ki67 | Clinical stage | Treatment | Disease specific survival |
|---|---|---|---|---|---|---|
1 | CD20 + CD3 − DLBCL | 8x4x2 cm | NA | IIE | Lobo-isthmectomy + chemotherapy (CHOP) + ritiximab | 26 months |
2 | CD79a + CD20 + Bcl2 + CD138 − DLBCL | 14x2x5 cm | 10% | IE | Thyroidectomy + cervical lymphadenectomy + Radiotherapy(30Gy) | 2 years |
3 | CD20 + DLBCL | 11x4x2 cm | 20% | IE | Thyroidectomy + cervical lymphadenectomy | died immediately after surgery |
4 | DLBCLCD20 + | 10,5 x5.6 x 6 cm | 25% | IV | Thyroidectomy | died immediately after surgery |
5 | DLBCLCD20 + | 5x2x2 cm | 15% | IE | Lobo-isthmectomy + chemotherapy (CHOP) + radiotherapy 30Gy | 3 years |